Received Oct 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7523J | — |
a patient experience pain in the shoulder; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of shoulder pain in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number 7523J, expiry date 02-MAY-2027) for prophylaxis. On 21-AUG-2025, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shoulder pain (Verbatim: a patient experience pain in the shoulder). The outcome of the shoulder pain was unknown. It was unknown if the reporter considered the shoulder pain to be related to Shingrix. It was unknown if the company considered the shoulder pain to be related to Shingrix. Additional Information: GSK Receipt Date: 13-OCT-2025 Registered pharmacist reported that a patient experienced pain in the shoulder after the administration of Shingrix. Vaccination date, vaccine detail and patient demographics were obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.